Search results
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 3 days agoThe cancer vaccine reduced the likelihood cancer would return or patients would die by 49% after...
Why Africa is facing an uphill battle to make its own vaccines
The Telegraph via Yahoo News· 4 days agoBiotechnology analysts believe that mRNA will become the superior vaccine technology within the next...
US opens COVID vaccine to little kids, shots begin next week
AOL· 6 days agoThe U.S. on Saturday opened COVID-19 vaccines to infants, toddlers and preschoolers. The shots will...
A Better Concept For mRNA Vaccines: Self-Amplification
Forbes· 7 days agoTwo new self-amplifying mRNA vaccines herald a new era of vaccination for coronaviruses.
Safe and Effective? The New York Times Revisits the COVID Jab. - The American Spectator | USA News...
American Spectator· 2 days agoIt has taken three years, but the New York Times has finally admitted that maybe, just maybe, there are some serious side effects to COVID vaccines. AstraZeneca, which has ...
Why Moderna Partnered with OpenAI
Analytics India Magazine· 6 days agoModerna plans to use ChatGPT Enterprise for mRNA medicine development to launch up to 15 new products in the next five years, including a vaccine for RSV...
Donald Trump Slams Bill Maher’s ‘Really Boring’ Interview With ‘LIBERAL’ RFK Jr.: ‘He Has No Hope’
The Wrap via Yahoo News· 7 days agoKennedy, he continues, was thrown out of the Democratic Party “like a dog” The post Donald Trump...
CDC Found Evidence COVID-19 Vaccines Caused Deaths
WSAU Wausau· 4 days agoIn an exclusive report by the Epoch Times, U.S. Centers for Disease Control and Prevention (CDC) officials fou...
Personalized Melanoma Vaccine Could Be a 'Game Changer' by Teaching the Body to Fight Cancer Cells
Smithsonian Magazine· 6 days agoA global trial has begun for the world’s first personalized vaccine for melanoma—the deadliest form of skin cancer, which affects about 132,000 people per year. If successful ...
First cancer jab trial finds they 'weaponise immunse system to attack tumours'
The US Sun· 4 days agoA NEW mRNA cancer vaccine can reprogram the immune system to attack tumours within 48 hours, a study shows. The first-ever human clinical trial of four adult patients showed ...